News Articles Network

Health and Fitness
RSS FeedJSON FeedXML FeedCSV Feed
Thu, November 14, 2024
[ 09:58am GMT ] - Country: United States, Nathan Burkes
The many benefits of excercise
Tue, November 12, 2024
[ 15:44pm GMT ] - Country: United States, Nathan Burkes
The Best Exercises to Stay in Shape
Sat, June 10, 2017
[ 07:57am GMT ] - Country: United States, Market Wire
Lilly's Galcanezumab Significantly Reduces Number .. r Patients with Migraine: New Results Presented a
Sat, June 3, 2017
[ 08:24am GMT ] - Country: United States, Market Wire
Lilly Builds Upon Body of Data for Abemaciclib wi .. monstrating Superior Progression-Free Survival in
Wed, May 31, 2017
[ 01:12am GMT ] - Country: United States, Market Wire
Lilly Announces Phase 3 RANGE Urothelial Cancer T .. Met Primary Endpoint, Improving Progression-Free
Wed, May 17, 2017
[ 11:58am GMT ] - Country: United States, Market Wire
Lilly to Present Results from Pivotal Breast Canc .. f Abemaciclib and New Portfolio Data at ASCO 2017
Fri, May 12, 2017
[ 00:58am GMT ] - Country: United States, Market Wire
Lilly Announces Positive Results for Three Phase .. r the Prevention of Episodic and Chronic Migraine
Thu, May 11, 2017
[ 10:26am GMT ] - Country: United States, Market Wire
BioLife Solutions Announces Q1 2017 Financial Results
Tue, May 9, 2017
[ 10:12am GMT ] - Country: United States, Market Wire
FDA Grants BAVENCIO (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Thu, May 4, 2017
[ 00:43am GMT ] - Country: United States, Market Wire
BioLife Solutions to Report First Quarter 2017 Fi .. sults and Provide Business Update on May 11, 2017
Thu, April 20, 2017
[ 06:04am GMT ] - Country: United States, Market Wire
Lilly to Present Data for Galcanezumab for the Pr .. merican Academy of Neurology (AAN) Annual Meeting
Fri, April 14, 2017
[ 03:19am GMT ] - Country: United States, Market Wire
U.S. FDA Issues Complete Response Letter for Baricitinib
Thu, March 23, 2017
[ 06:18am GMT ] - Country: United States, Market Wire
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration
Fri, March 17, 2017
[ 02:04am GMT ] - Country: United States, Market Wire
First dedicated outcome trials of empagliflozin in chronic heart failure initiated
Thu, March 9, 2017
[ 13:05pm GMT ] - Country: United States, Market Wire
BioLife Solutions Reports 4th Quarter and Full Year 2016 Results

Health and Fitness

Contributing Sources

Market Wire

Nathan Burkes